Cancer center spins off diagnostic company

Article

The Barbara Ann Karmanos Cancer Institute has launched a new company to build and market a breast cancer screening device invented at the institute, one that uses ultrasound and computer algorithms to assess patients.

The Barbara Ann Karmanos Cancer Institute has launched a new company to build and market a breast cancer screening device invented at the institute, one that uses ultrasound and computer algorithms to assess patients. The spin-off company, called Delphinus Medical Technologies, is dedicated to developing SoftVue as a commercial product. Clinical research has been conducted under an investigational device exemption from the FDA. The company is currently pursuing FDA approval to sell products based on the technology in the U.S. More than 300 women have been studied in initial clinical trials, which the company says has confirmed SoftVue as safe and accurate in identifying breast cancer.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
Emerging Trends in Breast Imaging: An Interview with Zeeshan Shah, MD
Diagnostic Imaging’s Top Five Breast Imaging Content: Summer 2025
Reducing Mammography Workload by Nearly 40 Percent? What a New Hybrid AI Study Reveals
© 2025 MJH Life Sciences

All rights reserved.